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doi:10.1016/j.joca.2011.10.008The challenge of disease deﬁnition in osteoarthritis (OA)
continues to grow. As described by Pereira et al., in a recent issue
of Osteoarthritis and Cartilage (OAC), there are substantial differ-
ences in prevalence and incidence estimates when deﬁning OA by
radiographic changes alone, as symptomatic OA (requiring a combi-
nation of both symptoms and radiographic change) or as self-
reported OA, using patient/participant self-report of a previous
OA diagnosis1. The authors ﬁnd, not surprisingly to those in the
ﬁeld, a higher prevalence of radiographic OA in comparison to the
symptomatic deﬁnitions. What may be more surprising is the close
relationship between symptomatic OA, which requires both radio-
graphs and a report of symptoms, and self-reported OA, requiring
perhaps only a single question, both having a prevalence w10–
40% lower than that estimated based on radiographic OA. The esti-
mates are most dissimilar for hand OA, which has a remarkably
high radiographic prevalence on the order of 50%, but is symptom-
atic in 15% and reported by only 5% in the pooled estimates. In
contrast, the prevalence estimates for hip OA are more comparable,
with a radiographic prevalence of 15%, symptomatic prevalence of
6%, and was reported by 7% of subjects (Fig. 1).
As discussed by the authors, even these three seemingly
straightforward deﬁnitions are highly variable across studies.
Radiographic OA can be determined based on one of many available
scoring systems, including theKellgren–Lawrence scale, assessment
of individual radiographic features such as osteophytes or joint
space narrowing and their combinations, or quantitative assess-
ment of joint space width. These measures are most commonly
applied to the knee, and may be less reliable at other joint sites.
Hand OA, in particular, is a challenge to deﬁne. Should one distal
interphalangeal joint with a Kellgren–Lawrence grade 2 deﬁne
OA of the hand, or should multiple, bilateral joint involvement be
required2? While Pereira et al. have necessarily combined different
radiographic deﬁnitions to achieve their goal of pooled prevalence
estimates, such differences in radiographic deﬁnition are likely
responsible for the greater variation demonstrated in the forest
plots (Pereira et al., Figures 2–5) among radiographic OA prevalence
estimates compared to symptomatic or self-report estimates1.
The concept of symptomatic OA is attractive to clinicians, as it
seems to represent the best of both worlds, by combining informa-
tion on structural damage with the patient’s symptoms. However,Research Society International. Puby deﬁning symptomatic OA as requiring radiographic changes
and symptoms in the same joint, all of the issues noted above for
radiographic deﬁnitions remain, with the added question of how
symptoms should be deﬁned. What is the time frame? The last
year, month, week? How frequently should symptoms have
occurred over that time? Are we concerned only with pain, or
also with aching and stiffness? How should we quantify severity?
These questions only multiply when progression, in addition to
presence of disease, is considered.
Self-report deﬁnitions have the distinct advantage of not
requiring a clinical examination or imaging studies, making them
a good option for large population studies and studies in commu-
nity settings, but are also problematic. Many individuals are not
aware of their clinical diagnosis and may have other forms of
arthritis, or arthralgias, and not OA. There may even be confusion
in patient’s minds between OA and other non-arthritic diseases,
such as osteoporosis. An assumption that one’s pain is due to OA
may be made when in reality there is a tendinopathy, bursitis,
impingement, or other soft tissue condition. It is therefore very
compelling that the estimates for self-reported OA prevalence, at
all sites, in the Pereira et al. report closely mirrored those for symp-
tomatic OA, which is a much more burdensome assessment.
Another important consideration for prevalence studies is the
population being assessed. While population-based studies use
methods (standardization, census weighting, enumeration, etc) to
ensure generalizability, studies of disease frequency using hospital
or clinic-based groups of patients may have characteristics unique
to that group that may not be representative of true population
prevalence. Pereira et al.mention this issue and report a sensitivity
analysis to estimate the inﬂuence of prevalence estimates from
“hospital-based” compared to other studies. Further review of the
studies considered “hospital-based” by the authors shows that
some of these were in fact population-based3–6 while others
were convenience samples of clinic or hospital patients7–9.
A clearer deﬁnition of “hospital-based studies” or perhaps a sensi-
tivity analysis comparing the studies that were population-based to
those that were not, may help to better understand these differ-
ences. A related issue is the wide variation among ethnic groups
for OA at different joint sites, which makes pooled estimates across
populations, although appealing, not particularly informative.blished by Elsevier Ltd. All rights reserved.
Fig. 1. Diagrammatic representation of the overlap between radiographic, symptom-
atic, and self-report deﬁnitions of OA.
Editorial / Osteoarthritis and Cartilage 20 (2012) 1–32While radiographic, symptomatic, and self-report have been the
most commonly utilized ways to deﬁne incident and prevalent
OA to date; there are multitudes of other potential ways to deﬁne
OA. These include deﬁnitions based on other imaging modalities,
such as the magnetic resonance imaging (MRI) deﬁnition
currently under development10 or ultrasound-based determina-
tions11. Assessed joint sites vary across studies, and phenotypic
deﬁnitions including combinations of joints may be considered in
addition to single joints2,12. Clinical deﬁnitions such as those of
the American College of Rheumatology are based primarily on
history and examination ﬁndings, such as pain, aching, or stiffness,
crepitus, and bony enlargement, without requiring radiographs for
conﬁrmation of the diagnosis13. Alternative phenotypic deﬁnitions
could be based on risk factors, such as injury, obesity, or malalign-
ment, or on outcomes such as performance measures or functional
limitations.
So what phenotypes and/or disease deﬁnitions are important in
OA? It likely depends on the question to be answered. For clinicians,
symptoms are paramount, as symptoms, not radiographic or other
imaging changes, bring a person to the doctor. For bone and carti-
lage researchers, structural and microstructural changes are most
important and may provide clues into pathogenesis and mecha-
nisms of disease initiation and progression. Those developing drugs
and performing clinical trials may be interested in symptom and/or
structural modiﬁcation. Groups studying systemic outcomes, such
as serum/urine biomarkers and genetic markers, have a particular
challenge to face. While these systemic markers are often used in
association with a local phenotype, such as a Kellgren–Lawrence
grade of 2 or more in a given joint, or a total joint replacement,
such systemic measurements must reﬂect the whole person and
not just a single joint. Therefore, while challenging, it may be
more reasonable to use a measure of whole-body disease burden
in such studies. For structural change, this might include multiple
joint radiographic assessments, while for symptomatic outcomes
or pain, assessments at the person-level would include the other
complexities that inﬂuence pain, such as mood, coping strategies,
catastrophizing behavior, support, socioeconomic status, etc. For
researchers, it is essential to consider the phenotype to be assessed
in a given study, and to collect all of the relevant information to
deﬁne that phenotype, whether it is of incidence, prevalence,
progression, psychosocial factors, or genetic inﬂuence. This also
highlights the need for readers of the literature in OA to be awareof the phenotype being used, how it was determined/deﬁned,
and the assumptions that were made, in order to better understand
the implications of the study.
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